Andrew McCullough

No ORCID on file · 1 paper in corpus
article 2013
·doi:10.1111/jsm.12320

INTRODUCTION: Current U.S. Food and Drug Administration-approved therapies for hypogonadism involve testosterone (T) replacement. Testosterone pellets (TP) require a minor office procedure every 3 to 4 months. The need for repeated insertio…